Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01608906 · ClinicalTrials.gov registry record · NA
Using Intravenous Heparin Versus Standard of Care Subcutaneous Heparin to Prevent Clots After Surgery
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 152
- Enrollment target
NCT01608906 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 152 participants.
The verdict
NCT01608906, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
Study Summary
This study plans to learn more about what is the best treatment to prevent blood clots in patients in intensive care units (ICU's). The investigators know that patients who are in ICU's have a higher than normal risk of getting blood clots in the veins of their arms or legs. This can be very dangerous as the clot may move into the lungs. To prevent this, the standard treatment is to give low dose heparin subcutaneously 3 times a day (usually 5000 units at each dose). In this study the investigators are randomizing patients to receive either standard of care or low dose intravenous heparin in a continuous infusion.
Interventions
- DRUG Heparin
- DRUG low dose intravenous heparin (LDIVH)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2007-05 |
| Est. Completion | 2014-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01608906
The ClinicalTrials.gov registry entry for NCT01608906 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Heparin is the first listed.
NCT01608906 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01608906 about?
NCT01608906 is a clinical study titled "Using Intravenous Heparin Versus Standard of Care Subcutaneous Heparin to Prevent Clots After Surgery". This study plans to learn more about what is the best treatment to prevent blood clots in patients in intensive care units (ICU's). The investigators know that patients who are in ICU's have a higher than normal risk of getting blood clots in the veins of their arms or legs. This can be very dangero...
What is the current status of trial NCT01608906?
This trial is currently completed. It is a NA study. The enrollment target is 152 participants. The study started on 2007-05. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01608906?
The interventions under investigation include: Heparin (DRUG), low dose intravenous heparin (LDIVH) (DRUG).
Who is sponsoring clinical trial NCT01608906?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.